PubMed COVID-19 Clinical Care
3711 - 3720 of 5506 results found
COVID-19 outcomes in people living with HIV: Peering through the waves
Description
CONCLUSIONS: Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group.
Consultations during COVID: Effects of a Pandemic on Neurosurgical Care
Description
CONCLUSION: The COVID pandemic significantly altered the demographics of our Neurosurgical Emergency Room patient population and continues to do so.
Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions
Description
CONCLUSION: Overall, our results show that combining nano-curcumin with catechin has a more notable impact on the enhancement of TCD4+, TCD8+, and Treg cells, as well as a decrease in Th17 cells and their mediators, suggesting a promising combination
COVID-19 and income inequality in OECD countries: a methodological comment-a reply
Description
No abstract
COVID-19 effects on diet, sleep, and physical activity among mid- to late-adolescents residing in the deep south in the United States
Description
CONCLUSIONS: This study diversifies the literature on the impact of COVID-19 and its mitigation measures on adolescents' social health. Further, it is based in the US's Deep South, largely populated by those identifying as Black/African American or
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation
Description
CONCLUSIONS/INTERPRETATION: Diagnosis of presymptomatic type 1 diabetes in children followed by education and monitoring improved clinical presentation at the onset of stage 3 type 1 diabetes.
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination
Description
CONCLUSION: Although statistically significant changes in haemostasis markers have been obtained, they remained clinically irrelevant. Thus, our study implicates that there is no plausible scientific evidence of a significant disruption in the
Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories
Description
Dysregulated human peptidases are implicated in a large variety of diseases such as cancer, hypertension, and neurodegeneration. Viral proteases for their part are crucial for the pathogens' maturation and assembly. Several decades of research were
